Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Malignant Melanoma

  Free Subscription


Articles published in J Am Acad Dermatol

Retrieve available abstracts of 226 articles:
HTML format



Single Articles


    August 2022
  1. MARCAILLOU M, Dion J, Baroudjian B, Ezrine E, et al
    Sample CME manuscript submission: Response to the article by Pham et al entitled "Review BRAF inhibition and the spectrum of granulomatous reactions".
    J Am Acad Dermatol. 2022;87:e85-e88.
    PubMed    


  2. LEE JS, Kim S, Kim DH, Lee JW, et al
    Clinical features and natural course of pediatric longitudinal melanonychia: A retrospective cohort study in Korea.
    J Am Acad Dermatol. 2022;87:366-372.
    PubMed     Abstract available


  3. PEREZ M, Abisaad JA, Rojas KD, Marchetti MA, et al
    Skin cancer: Primary, secondary, and tertiary prevention. Part I.
    J Am Acad Dermatol. 2022;87:255-268.
    PubMed     Abstract available


    July 2022
  4. PAN CX, Yang K, Lau CB, Zhou G, et al
    Non-melanoma skin cancer in patients with hereditary hemochromatosis: a case-control study.
    J Am Acad Dermatol. 2022 Jul 21. pii: S0190-9622(22)02400.
    PubMed    


  5. JARELL A, Gastman BR, Dillon LD, Hsueh EC, et al
    Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test.
    J Am Acad Dermatol. 2022 Jul 7. pii: S0190-9622(22)02253.
    PubMed     Abstract available


  6. MULLIGAN KM, Cullison CR, Zheng DX, Rothermel LD, et al
    Mucosal melanoma and organ-specific metastasis: Differences in survival outcomes between tumor primary sites.
    J Am Acad Dermatol. 2022 Jul 5. pii: S0190-9622(22)02248.
    PubMed    


  7. XIONG DD, Barriera-Silvestrini P, Knackstedt TJ
    Delays in surgical treatment of melanoma are associated with worsened overall and melanoma-specific mortality: a population-based analysis.
    J Am Acad Dermatol. 2022 Jul 1. pii: S0190-9622(22)02239.
    PubMed     Abstract available


    June 2022
  8. TREPANOWSKI N, Chang MS, Zhou G, Ahmad M, et al
    Delays in melanoma presentation during the COVID-19 pandemic: a nationwide multi-institutional cohort study.
    J Am Acad Dermatol. 2022 Jun 20. pii: S0190-9622(22)01023.
    PubMed    


  9. CHOI ME, Won CH, Chang SE, Lee MW, et al
    Clinical and Prognostic Influence of Tumor Diameter in Acral Lentiginous Melanoma.
    J Am Acad Dermatol. 2022 Jun 17. pii: S0190-9622(22)01019.
    PubMed    


  10. ELSTON DM
    Letter from the editor: Delays in Melanoma Diagnosis.
    J Am Acad Dermatol. 2022 Jun 16. pii: S0190-9622(22)01011.
    PubMed    


  11. KUMAR AB, Peters MS, Jakub JW, Harmsen W, et al
    "Primary cutaneous melanoma features predict development of intransit metastases/satellite lesions: Mayo Clinic experience 2010-2014".
    J Am Acad Dermatol. 2022 Jun 13. pii: S0190-9622(22)00994.
    PubMed    


  12. BLUMENTHAL LY, Hu JC
    Response to "Comment on 'Racial/Ethnic disparities in non-melanoma skin cancer based on Mohs micrographic surgery defect size, a multicenter retrospective study'".
    J Am Acad Dermatol. 2022 Jun 2. pii: S0190-9622(22)00902.
    PubMed    


    May 2022
  13. KURN HA, Abercrombie M, Tzellos T, Dellavalle RP, et al
    From the Cochrane Library: Interventions for Melanoma in Situ, Including Lentigo Maligna.
    J Am Acad Dermatol. 2022 May 28. pii: S0190-9622(22)00889.
    PubMed    


  14. SCHARF C, Brancaccio G, Di Stefani A, Fargnoli MC, et al
    THE ASSOCIATION BETWEEN LOCKDOWNS DURING THE COVID-19 PANDEMIC AND MELANOMA DIAGNOSIS: A MULTICENTER RETROSPECTIVE STUDY FROM EUROPE.
    J Am Acad Dermatol. 2022 May 16. pii: S0190-9622(22)00812.
    PubMed    


  15. LUU YT, Goldstein AM, Sargen MR
    Variation in second cancer risk by melanoma subtype among survivors.
    J Am Acad Dermatol. 2022 May 16. pii: S0190-9622(22)00816.
    PubMed    


  16. SHAIKH SS, Yang X, Fortman DD, Wang H, et al
    A Retrospective Analysis of the Impact of the COVID-19 Pandemic on Staging at Presentation of Patients with Invasive Melanoma.
    J Am Acad Dermatol. 2022 May 9. pii: S0190-9622(22)00798.
    PubMed    


  17. BRUNSGAARD E, Wu YP, Grossman D
    Melanoma in Skin of Color: Part I. Epidemiology and clinical presentation.
    J Am Acad Dermatol. 2022 May 6. pii: S0190-9622(22)00783.
    PubMed     Abstract available


  18. BRUNSGAARD E, Jensen J, Grossman D
    Melanoma in Skin of Color: Part II. Racial disparities, role of UV, and interventions for earlier detection.
    J Am Acad Dermatol. 2022 May 6. pii: S0190-9622(22)00784.
    PubMed     Abstract available


  19. SARVER MM, Rames JD, Beasley GM, Gao J, et al
    Survival and Tumor Characteristics of Patients Presenting with Single Primary vs. Second Primary Melanoma Lesions.
    J Am Acad Dermatol. 2022 May 4. pii: S0190-9622(22)00715.
    PubMed     Abstract available


  20. CONDORELLI AG, Farnetani F, Ciardo S, Chester J, et al
    Dynamic dermoscopic and reflectance confocal microscopic changes of melanocytic lesions excised during follow up.
    J Am Acad Dermatol. 2022;86:1049-1057.
    PubMed     Abstract available


  21. SOENEN A, Vourc'h M, Khammari A, Nguyen JM, et al
    Change in lentigo maligna score assessed by in vivo reflectance confocal microscopy after 1 month of imiquimod treatment for lentigo maligna management.
    J Am Acad Dermatol. 2022;86:1042-1048.
    PubMed     Abstract available


    April 2022
  22. MORAES AFA, Blumetti TCMP, Pinto C, Bertoli E, et al
    Melanoma with peripheral globules: clinical and dermoscopic features.
    J Am Acad Dermatol. 2022 Apr 26. pii: S0190-9622(22)00697.
    PubMed     Abstract available


  23. STRAKER RJ 3RD, Sharon CE, Chu EY, Miura JT, et al
    Sentinel lymph node biopsy in patients with clinical stage IIB/C cutaneous melanoma: A national cohort study.
    J Am Acad Dermatol. 2022 Apr 22. pii: S0190-9622(22)00681.
    PubMed     Abstract available


    March 2022
  24. HOBAYAN CGP, Grant-Kels JM, Korman AM
    The ethics of dismissing a melanoma patient who repeatedly no-shows.
    J Am Acad Dermatol. 2022 Mar 19. pii: S0190-9622(22)00504.
    PubMed    


  25. CHANG MS, La J, Trepanowski N, Cheng D, et al
    Increased relative proportions of advanced melanoma among Veterans: a comparative analysis with the SEER registry.
    J Am Acad Dermatol. 2022 Mar 9. pii: S0190-9622(22)00392.
    PubMed     Abstract available


  26. WONGVIBULSIN S, Pahalyants V, Kalinich M, Murphy W, et al
    Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis.
    J Am Acad Dermatol. 2022;86:563-572.
    PubMed     Abstract available


    February 2022
  27. ASDOURIAN MS, Otto TS, Jacoby TV, Shah N, et al
    Association between serum LDH and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma.
    J Am Acad Dermatol. 2022 Feb 19. pii: S0190-9622(22)00335.
    PubMed    


  28. EL SHAROUNI MA, Rawson RV, Sigurdsson V, Witkamp AJ, et al
    The progressive relationship between increasing Breslow thickness and decreasing survival is lost in patients with ultra-thick melanomas (>/=15mm in thickness).
    J Am Acad Dermatol. 2022 Feb 1. pii: S0190-9622(22)00174.
    PubMed     Abstract available


    January 2022
  29. PRASAD S, Black S, Chen HW, Joseph A, et al
    Beliefs and barriers to care of primary care practitioners towards melanoma screening and education in rural Texas.
    J Am Acad Dermatol. 2022 Jan 22. pii: S0190-9622(22)00091.
    PubMed    


  30. MUZUMDAR S, Wu R, Rothe MJ, Grant-Kels JM, et al
    Reflectance confocal microscopy decreases the cost of skin lesion diagnosis: A single institution retrospective chart review.
    J Am Acad Dermatol. 2022;86:209-211.
    PubMed    


    December 2021
  31. SKUDALSKI L, Waldman R, Kerr PE, Grant-Kels JM, et al
    Melanoma: How and When to Consider Clinical Diagnostic Technologies.
    J Am Acad Dermatol. 2021 Dec 13. pii: S0190-9622(21)02971.
    PubMed     Abstract available


  32. SKUDALSKI L, Waldman R, Kerr PE, Grant-Kels JM, et al
    Melanoma: An Update on Systemic Therapies.
    J Am Acad Dermatol. 2021 Dec 13. pii: S0190-9622(21)02970.
    PubMed     Abstract available


  33. GOLDSMITH SM
    Comment on "Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas".
    J Am Acad Dermatol. 2021;85:e361.
    PubMed    


  34. VASICEK B, Erickson T, Lake E
    Comment on "Descriptive survival study of nail melanoma patients treated with functional surgery versus distal amputation".
    J Am Acad Dermatol. 2021;85:e351.
    PubMed    


  35. MONTAGNER S
    Reply to: "Comment on 'Descriptive survival study of nail melanoma patients treated with functional surgery versus distal amputation'".
    J Am Acad Dermatol. 2021;85:e353.
    PubMed    


  36. OKHOVAT JP, Davine JA, Hawryluk EB, Geller AC, et al
    Educational brochure impact on postscreening practices of American Academy of Dermatology skin cancer screening participants.
    J Am Acad Dermatol. 2021;85:1616-1617.
    PubMed    


  37. ZAKHEM GA, Fakhoury JW, Motosko CC, Ho RS, et al
    Characterizing the role of dermatologists in developing artificial intelligence for assessment of skin cancer.
    J Am Acad Dermatol. 2021;85:1544-1556.
    PubMed     Abstract available


    November 2021
  38. KURN HA, Sivesind TE, Dellavalle RP
    From the Cochrane Library: Screening for Reducing Morbidity and Mortality in Malignant Melanoma.
    J Am Acad Dermatol. 2021 Nov 25. pii: S0190-9622(21)02909.
    PubMed    


  39. RAVAL NS, Hodges WT, Ugwu-Dike PO, Godoy F, et al
    Racial and socioeconomic differences in acral lentiginous melanoma outcomes: a SEER analysis.
    J Am Acad Dermatol. 2021 Nov 20. pii: S0190-9622(21)02856.
    PubMed    


  40. THORPE RB, Covington KR, Caruso HG, Quick AP, et al
    Development and validation of a nomogram incorporating gene expression profiling and clinical factors for accurate prediction of metastasis in patients with cutaneous melanoma following Mohs micrographic surgery.
    J Am Acad Dermatol. 2021 Nov 19. pii: S0190-9622(21)02854.
    PubMed     Abstract available


  41. KANTOR J
    This Month in JAAD International: February 2022: Vitiligo in melanoma patients treated with anti-PD-1 therapies and improved survival.
    J Am Acad Dermatol. 2021 Nov 6. pii: S0190-9622(21)02749.
    PubMed    


  42. SOENEN A, Vourc'h M, Dreno B, Chiaverini C, et al
    Diagnosis of congenital pigmented macules in infants with reflectance confocal microscopy and machine learning.
    J Am Acad Dermatol. 2021;85:1308-1309.
    PubMed    


  43. MAZMUDAR RS, Fazio J, Garland K, Tripathi R, et al
    Predictors of patient-initiated communication after Mohs micrographic surgery: A multi-institutional prospective cohort study.
    J Am Acad Dermatol. 2021;85:1290-1293.
    PubMed    


  44. GOMEZ-MARTIN I, Collgros H, Ferguson PM, Barreiro A, et al
    Diagnostic accuracy of pigmented labial macules by in vivo reflectance confocal microscopy and correlation among techniques.
    J Am Acad Dermatol. 2021;85:1151-1160.
    PubMed     Abstract available


  45. TRIPATHI R, Bordeaux JS, Nijhawan RI
    Utilization of palliative therapy for metastatic melanoma in the United States.
    J Am Acad Dermatol. 2021;85:1342-1345.
    PubMed    


  46. CHANG MS, Huang L, Mostaghimi A, Hartman RI, et al
    Lifetime history of total body skin examinations in patients with disabilities: Examining for differences in skin cancer screening.
    J Am Acad Dermatol. 2021;85:1326-1328.
    PubMed    


    October 2021
  47. FARAH M, Chung HJ
    Diagnostic Utility of PRAME Immunohistochemistry in the Evaluation of Melanomas with a Co-existent Nevoid Melanocytic Population: A Single Center Retrospective Cohort Study.
    J Am Acad Dermatol. 2021 Oct 28. pii: S0190-9622(21)02714.
    PubMed    


  48. IPENBURG NA, El Sharouni MA, van Doorn R, van Diest PJ, et al
    Lack of association between CDKN2A germline mutations and survival in melanoma patients: a retrospective cohort study.
    J Am Acad Dermatol. 2021 Oct 22. pii: S0190-9622(21)02677.
    PubMed    


  49. LIN JQ, Li SQ, Li S, Kiamanesh EF, et al
    A 10-year retrospective cohort study of ruxolitinib and association with non-melanoma skin cancer in polycythemia vera and myelofibrosis patients.
    J Am Acad Dermatol. 2021 Oct 11. pii: S0190-9622(21)02632.
    PubMed     Abstract available


  50. LITCHMAN GH, Teplitz RW, Marson JW, Rigel DS, et al
    Impact of electrical impedance spectroscopy on dermatologists' number needed to biopsy metric and biopsy decisions for pigmented skin lesions.
    J Am Acad Dermatol. 2021;85:976-979.
    PubMed    


    September 2021
  51. GAGHAN LJ, Bui H, Lipner SR, Jellinek NJ, et al
    Evaluation of a community education tool for detection of nail melanoma by nail salon technicians.
    J Am Acad Dermatol. 2021 Sep 21. pii: S0190-9622(21)02503.
    PubMed    


  52. BLUMENTHAL LY, Arzeno J, Syder N, Rabi S, et al
    Disparities in non-melanoma skin cancer in Hispanic/Latino patients based on Mohs micrographic surgery defect size, a multicenter retrospective study.
    J Am Acad Dermatol. 2021 Sep 4. pii: S0190-9622(21)02423.
    PubMed     Abstract available


  53. LALLAS A, Kyrgidis A, Manoli SM, Papageorgiou C, et al
    Delayed skin cancer diagnosis in 2020 because of the COVID-19-related restrictions: Data from an institutional registry.
    J Am Acad Dermatol. 2021;85:721-723.
    PubMed    


    August 2021
  54. MCFEELY O, Hollywood A, Stanciu M, O'Connell M, et al
    Comment on "The Impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: a single institution experience".
    J Am Acad Dermatol. 2021 Aug 28. pii: S0190-9622(21)02383.
    PubMed    


  55. STRAKER RJ 3RD, Kelly N, Sharon CE, Shannon AB, et al
    Local recurrence in patients undergoing wide excision and sentinel lymph node biopsy for cutaneous malignant melanoma: A single-center, retrospective cohort analysis.
    J Am Acad Dermatol. 2021 Aug 12. pii: S0190-9622(21)02299.
    PubMed    


  56. YAN BY, Barilla S, Strunk A, Garg A, et al
    Survival Differences in Acral Lentiginous Melanoma According to Socioeconomic Status and Race.
    J Am Acad Dermatol. 2021 Aug 4. pii: S0190-9622(21)02210.
    PubMed     Abstract available


  57. PARISI R, Huppertz J, Potolski A, Tracey V, et al
    Distance to Diagnosing Dermatology Provider as a Predictor of Multiple Melanoma Diagnoses.
    J Am Acad Dermatol. 2021 Aug 3. pii: S0190-9622(21)02214.
    PubMed    


  58. KANTOR J
    August 2021: On the epistemology of Breslow thickness and histopathologic melanoma subtype.
    J Am Acad Dermatol. 2021;85:318.
    PubMed    


  59. WANG TS, Griffiths CC, Roman EM
    Should topical imiquimod be used for positive margins in lentigo maligna?
    J Am Acad Dermatol. 2021;85:521-522.
    PubMed    


    July 2021
  60. GAUDY-MARQUESTE C, Macagno N, Loundou A, Pellegrino E, et al
    Molecular characterization of fast-growing melanomas.
    J Am Acad Dermatol. 2021 Jul 16. pii: S0190-9622(21)02101.
    PubMed     Abstract available


  61. BUI AN, Bougrine A, Buchbinder EI, Giobbie-Hurder A, et al
    Female sex is associated with higher rates of dermatologic adverse events among patients with melanoma receiving immune checkpoint inhibitor therapy: a retrospective cohort study.
    J Am Acad Dermatol. 2021 Jul 9. pii: S0190-9622(21)02087.
    PubMed    


  62. STRAKER RJ 3RD, Thaler AS, Shannon AB, Miura JT, et al
    Acral lentiginous melanoma in the era of immune checkpoint blockade and targeted therapy: A National Cancer Database analysis.
    J Am Acad Dermatol. 2021 Jul 9. pii: S0190-9622(21)02095.
    PubMed    


    June 2021
  63. YOO H, Kim H, Kwon ST, Jo SJ, et al
    Tumor invasion in the hyponychium is associated with distant metastasis and poor prognosis in subungual melanoma: A histological landscape of 44 cases.
    J Am Acad Dermatol. 2021 Jun 18. pii: S0190-9622(21)01989.
    PubMed     Abstract available


  64. CARLET C, Dalle S, Leccia MT, Mortier L, et al
    Late-onset adverse events under anti-PD1 therapy in melanoma patients: an observational study from MELBASE, a nationwide prospective cohort.
    J Am Acad Dermatol. 2021 Jun 18. pii: S0190-9622(21)01991.
    PubMed     Abstract available


  65. FIGUEROA-SILVA O, Suarez-Penaranda JM, Balboa-Barreiro V, Rojas SA, et al
    Volume tumor impact on melanoma survival assessed through Breslow density.
    J Am Acad Dermatol. 2021 Jun 8. pii: S0190-9622(21)01107.
    PubMed    


  66. MUZUMDAR S, Lin G, Kerr P, Grant-Kels JM, et al
    Is Melanoma Overdiagnosed? A Review of the Evidence.
    J Am Acad Dermatol. 2021 Jun 8. pii: S0190-9622(21)01110.
    PubMed     Abstract available


  67. BEAULIEU D, Gao DX, Swetter SM, Hawryluk EB, et al
    Association between income and suspected non-melanoma and melanoma skin cancers among participants of the American Academy of Dermatology's SPOT Skin Cancer(R) screening program - A cross-sectional analysis.
    J Am Acad Dermatol. 2021 Jun 2. pii: S0190-9622(21)01044.
    PubMed    


  68. VAIDYA TS, Bander TS, Musthaq S, Lampley N 3rd, et al
    Validation of a patient decision aid for the treatment of lentigo maligna.
    J Am Acad Dermatol. 2021;84:1751-1753.
    PubMed    


  69. HANLON KL, Correa-Selm LM, Grichnik JM
    Application of 3-dimensional reflectance confocal microscopy: Melanocytic proliferations as three-dimensional models.
    J Am Acad Dermatol. 2021;84:1737-1739.
    PubMed    


  70. ELSTON D
    This Month in JAAD: June 2021.
    J Am Acad Dermatol. 2021;84:1542.
    PubMed    


  71. LONGO C, Mazzeo M, Raucci M, Cornacchia L, et al
    Dark pigmented lesions: Diagnostic accuracy of dermoscopy and reflectance confocal microscopy in a tertiary referral center for skin cancer diagnosis.
    J Am Acad Dermatol. 2021;84:1568-1574.
    PubMed     Abstract available


    May 2021
  72. GREEN AC, Hughes MCB, Williams GM, Malt M, et al
    Increased melanoma recurrence in patients with multiple primary invasive melanomas.
    J Am Acad Dermatol. 2021 May 27. pii: S0190-9622(21)01012.
    PubMed    


  73. BITTAR PG, Bittar JM, Etzkorn JR, Brewer JD, et al
    Systematic Review and Meta-Analysis of Local Recurrence Rates of Head and Neck Cutaneous Melanomas after Wide Local Excision, Mohs Micrographic Surgery, or Staged Excision.
    J Am Acad Dermatol. 2021 May 4. pii: S0190-9622(21)00937.
    PubMed     Abstract available


  74. CHANG MS, Hartman RI
    Melanoma healthcare and outcome disparities in the Veteran Affairs population.
    J Am Acad Dermatol. 2021 May 4. pii: S0190-9622(21)00938.
    PubMed    


    April 2021
  75. DUNCAN JR, Srikakolapu S, Daugherty A, Elston C, et al
    Cost Efficacy of Wide Local Excision of pT1a Melanoma in Office vs. Operating Room Settings.
    J Am Acad Dermatol. 2021 Apr 28. pii: S0190-9622(21)00920.
    PubMed    


  76. GRANT-KELS JM
    JAAD Game Changers: Comparison of surgical margins for lentigo maligna versus melanoma in situ.
    J Am Acad Dermatol. 2021 Apr 21. pii: S0190-9622(21)00887.
    PubMed    


  77. MILLER CJ, Etzkorn JR, Leitenberger JJ, Bar A, et al
    Commentary on "Limitations in the literature regarding Mohs surgery and staged excision for melanoma: A critical review of quality and data reporting".
    J Am Acad Dermatol. 2021 Apr 16. pii: S0190-9622(21)00770.
    PubMed    


  78. ADALSTEINSSON JA, Stoj VJ, Algzlan H, Swede H, et al
    Limitations in the Literature Regarding Mohs Surgery and Staged Excision for Melanoma: A Critical Review of Quality and Data Reporting.
    J Am Acad Dermatol. 2021 Apr 16. pii: S0190-9622(21)00772.
    PubMed     Abstract available


  79. AGGARWAL P, Knabel P, Fleischer AB Jr
    United States Burden of Melanoma and Non-Melanoma Skin Cancer from 1990 to 2019.
    J Am Acad Dermatol. 2021 Apr 11. pii: S0190-9622(21)00755.
    PubMed     Abstract available


  80. OLAMIJU B, Suozzi KC, Leffell DJ, Christensen SR, et al
    Clinical Factors Impacting Clear Margins of Primary Melanoma in Situ with Conventional Excision in a Retrospective Cohort.
    J Am Acad Dermatol. 2021 Apr 10. pii: S0190-9622(21)00764.
    PubMed    


  81. HEYMANN WR
    Melanoma Healthcare and Outcome Disparities: You Can Never Be Too Rich or Too Thin.
    J Am Acad Dermatol. 2021 Apr 3. pii: S0190-9622(21)00679.
    PubMed    


  82. LUKOWIAK TM, Perz AM, Aizman L, Kovell RC, et al
    Mohs micrographic surgery for male genital tumors: Local recurrence rates and patient-reported outcomes.
    J Am Acad Dermatol. 2021;84:1030-1036.
    PubMed     Abstract available


  83. WILLIAMS EA, Shah N, Danziger N, Montesion M, et al
    Clinical, histopathologic, and molecular profiles of PRKAR1A-inactivated melanocytic neoplasms.
    J Am Acad Dermatol. 2021;84:1069-1071.
    PubMed    


  84. MURZAKU EC, Shi K, Srivastava D, Nijhawan RI, et al
    Surgical management and practices in pregnancy and lactation: A survey of United States dermatologic surgeons.
    J Am Acad Dermatol. 2021;84:1134-1136.
    PubMed    


  85. EASON CD, Rundle C, Dunnick CA, Hugh J, et al
    National trends in free public sunscreen dispensers.
    J Am Acad Dermatol. 2021;84:1109-1111.
    PubMed    


    March 2021
  86. BAYERS S, Orseth M, Prasad S, Hynan LS, et al
    Community-based melanoma screening: A pilot study for the development of an educational curriculum for nonphysician providers.
    J Am Acad Dermatol. 2021 Mar 29. pii: S0190-9622(21)00362.
    PubMed    


  87. THOMPSON LL, Chang MS, Polyakov NJ, Blum AE, et al
    Prognostic significance of cutaneous immune-related adverse events in patients with melanoma and other cancers on immune checkpoint inhibitors.
    J Am Acad Dermatol. 2021 Mar 12. pii: S0190-9622(21)00563.
    PubMed    


  88. CULLISON CR, Tripathi R, Bordeaux JS
    Identifying sociodemographic factors associated with hospitalization following primary excision of cutaneous melanoma.
    J Am Acad Dermatol. 2021 Mar 2. pii: S0190-9622(21)00466.
    PubMed    


  89. PITNEY T, Muir DJ
    Single-center, single-operator, retrospective analysis of base transection rates in shave procedures for melanoma diagnosis.
    J Am Acad Dermatol. 2021;84:861-862.
    PubMed    


  90. MILLER RC, Stewart CR, Lipner SR
    Retrospective study of trends in dermatology telemedicine and in-person visits at an academic center during COVID-19.
    J Am Acad Dermatol. 2021;84:777-779.
    PubMed    


    February 2021
  91. KOBLINSKI JE, Maykowski P, Zeitouni NC
    Disparities in melanoma stage at diagnosis in Arizona: A 10-Year Arizona Cancer Registry Study.
    J Am Acad Dermatol. 2021 Feb 20. pii: S0190-9622(21)00404.
    PubMed    


  92. GILLSTEDT M, Hedlund E, Paoli J, Polesie S, et al
    Discrimination between Invasive and In situ Melanomas Using a Convolutional Neural Network.
    J Am Acad Dermatol. 2021 Feb 12. pii: S0190-9622(21)00336.
    PubMed    


  93. BRINKER TJ, Schmitt M, Krieghoff-Henning EI, Barnhill R, et al
    Diagnostic performance of artificial intelligence for histologic melanoma recognition compared to 18 international expert pathologists.
    J Am Acad Dermatol. 2021 Feb 10. pii: S0190-9622(21)00331.
    PubMed    


  94. GONZALEZ-CAO M, Carrera C, Rodriguez Moreno JF, Rodriguez-Jimenez P, et al
    COVID-19 in Melanoma Patients: Results of the Spanish Melanoma Group Registry, GRAVID study.
    J Am Acad Dermatol. 2021 Feb 10. pii: S0190-9622(21)00337.
    PubMed    


  95. STRAKER RJ 3RD, Song Y, Shannon AB, Chu EY, et al
    Association of the Affordable Care Act's Medicaid Expansion with the diagnosis and treatment of clinically localized melanoma: A National Cancer Database Study.
    J Am Acad Dermatol. 2021 Feb 4. pii: S0190-9622(21)00308.
    PubMed     Abstract available


  96. VOGEL RI, Jewett PI, Ahmed RL, Lazovich D, et al
    Comparison of sun exposure and protection behaviors between urban and rural residents without a history of melanoma in the Midwestern United States.
    J Am Acad Dermatol. 2021 Feb 3. pii: S0190-9622(21)00304.
    PubMed    


  97. LALLAS A, Lallas K, Tschandl P, Kittler H, et al
    The dermoscopic inverse approach significantly improves the accuracy of human readers for lentigo maligna diagnosis.
    J Am Acad Dermatol. 2021;84:381-389.
    PubMed     Abstract available


    January 2021
  98. POLESIE S, Gillstedt M
    Psoriasis and risk of cutaneous melanoma: a retrospective comparative registry-based cohort study.
    J Am Acad Dermatol. 2021 Jan 30. pii: S0190-9622(21)00244.
    PubMed    


  99. SCHWAB G, Gerami P, Fiessinger L, Nardone B, et al
    A comparison of the Breslow depth and all-cause survival of male and female genital melanomas.
    J Am Acad Dermatol. 2021 Jan 28. pii: S0190-9622(21)00216.
    PubMed    


  100. TAN A, Greenwald E, Bajaj S, Belen D, et al
    Melanoma surveillance for high-risk patients via telemedicine: Examination of real-world data from an integrated store-and-forward total body photography and dermoscopy service.
    J Am Acad Dermatol. 2021 Jan 27. pii: S0190-9622(21)00206.
    PubMed    


  101. NADELMAN DA, Ahn JW, VanKoevering KK, Smith NR, et al
    Research Letter: A Single Institution's Review of Patterns of Compliance with Melanoma Ultrasound Surveillance Recommendations.
    J Am Acad Dermatol. 2021 Jan 25. pii: S0190-9622(21)00225.
    PubMed    


  102. HU X, Kilgour JM, Fogel AL, Jia JL, et al
    Direct-to-Consumer Genetic Risk Scoring for Melanoma Improves Adherence to Sun-Protective Behaviors Among Increased-Risk Groups: Results from a Prospective U.S. Cohort Study.
    J Am Acad Dermatol. 2021 Jan 18. pii: S0190-9622(21)00191.
    PubMed    


  103. VARGAS-MORA P, Peruilh-Bagolini L, Gonzalez-Cuevas R, Ferrer-Rosende P, et al
    Impact of the time interval between primary melanoma excision and sentinel node biopsy: A systematic review and meta-analysis.
    J Am Acad Dermatol. 2021 Jan 16. pii: S0190-9622(21)00162.
    PubMed     Abstract available


  104. BHATT MD, Perz AM, Moioli E, Sobanko JF, et al
    The accuracy of detecting melanoma on frozen section MART-1 stains and on permanent sections of previously-frozen tissue: a prospective cohort study.
    J Am Acad Dermatol. 2021 Jan 13. pii: S0190-9622(21)00008.
    PubMed    


  105. WEI C, Allais B, Tornberg HN, Quan T, et al
    The utilization of the Altmetric and PlumX scores in evaluating the top 100 trending melanoma articles in social media.
    J Am Acad Dermatol. 2021 Jan 8. pii: S0190-9622(21)00084.
    PubMed    


  106. MARSON JW, Maner BS, Harding TP, Meisenheimer J VII, et al
    The Magnitude of COVID-19's Effect on the Timely Management of Melanoma and Non-Melanoma Skin Cancers.
    J Am Acad Dermatol. 2021 Jan 8. pii: S0190-9622(21)00082.
    PubMed    


  107. HARTMAN RI, La J, Chang MS, Cheng D, et al
    Risk factors for thick melanoma among Veterans: A cross-sectional study.
    J Am Acad Dermatol. 2021 Jan 7. pii: S0190-9622(21)00086.
    PubMed    


  108. MOUSTAFA D, Duncan LM, Hawryluk EB
    A 20-year histopathologic study of pediatric nevi at an academic institution.
    J Am Acad Dermatol. 2021;84:39-40.
    PubMed    


  109. LEWINSON RT, Meyers DE, Vallerand IA, Suo A, et al
    Machine learning for prediction of cutaneous adverse events in patients receiving anti-PD-1 immunotherapy.
    J Am Acad Dermatol. 2021;84:183-185.
    PubMed    


  110. NAVARRETE-DECHENT C, Liopyris K, Monnier J, Aleissa S, et al
    Reflectance confocal microscopy terminology glossary for melanocytic skin lesions: A systematic review.
    J Am Acad Dermatol. 2021;84:102-119.
    PubMed     Abstract available


    December 2020
  111. SHANNON AB, Sharon CE, Straker RJ 3rd, Miura JT, et al
    The Impact of the COVID-19 Pandemic on the Presentation Status of Newly Diagnosed Melanoma: A Single Institution Experience.
    J Am Acad Dermatol. 2020 Dec 19. pii: S0190-9622(20)33225.
    PubMed    


  112. MIGUEL BAF, Morgado-Carrasco D, Toll A, Perez-Anker J, et al
    Meshed keystone flap: A last-step modification to reduce tension and cover a larger surface.
    J Am Acad Dermatol. 2020;83:e397-e398.
    PubMed    


    November 2020
  113. DIKA E, Mastroeni S, Lambertini M, Scarfi F, et al
    The chronic use of multiple photosensitizing drugs is associated with Breslow thickness in female melanoma patients: A bicentric retrospective study.
    J Am Acad Dermatol. 2020 Nov 27. pii: S0190-9622(20)33097.
    PubMed    


  114. ALLAIS BS, Beatson M, Wang H, Shahbazi S, et al
    Five-Year Survival in Patients with Nodular and Superficial Spreading Melanomas in the US Population.
    J Am Acad Dermatol. 2020 Nov 27. pii: S0190-9622(20)33094.
    PubMed     Abstract available


  115. BARRIOS DM, Do MH, Phillips GS, Postow MA, et al
    Immune checkpoint inhibitors to treat cutaneous malignancies.
    J Am Acad Dermatol. 2020;83:1239-1253.
    PubMed     Abstract available


    October 2020
  116. BEHBAHANI S, Malerba S, Maniar A, Taback B, et al
    Outcomes and Predictors of Survival in Cutaneous Melanoma of the Eyelid: An Analysis of the National Cancer Database.
    J Am Acad Dermatol. 2020 Oct 31. pii: S0190-9622(20)32903.
    PubMed    


  117. KELM RC, Ali Y, Orrell K, Rangel SM, et al
    Age and sex differences for malignant melanoma in the pediatric population-childhood versus adolescence: analysis of current nationwide data from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program.
    J Am Acad Dermatol. 2020 Oct 24. pii: S0190-9622(20)32862.
    PubMed    


  118. NAVARRETE-DECHENT C, Aleissa S, Connolly K, Hibler BP, et al
    Clinical size is a poor predictor of invasion in melanoma of the lentigo maligna type.
    J Am Acad Dermatol. 2020 Oct 20. pii: S0190-9622(20)32835.
    PubMed     Abstract available


  119. SISCOS SM, Neill BC, Seger EW, Rajpara A, et al
    Practice habits of Mohs surgeons treating melanoma with Mohs surgery: a cross-sectional survey.
    J Am Acad Dermatol. 2020 Oct 3. pii: S0190-9622(20)32682.
    PubMed    


  120. SHI K, Kim D, Mohan LS, Garfield EM, et al
    A retrospective cohort study of the diagnostic value of different subtypes of atypical pigment network on dermoscopy.
    J Am Acad Dermatol. 2020;83:1028-1034.
    PubMed     Abstract available


  121. KINSER K, Barlow CE, Leonard D, Farrell SW, et al
    Tanning bed use and depression in a preventive medicine cohort: The Cooper Center Longitudinal Study.
    J Am Acad Dermatol. 2020;83:1200-1202.
    PubMed    


  122. YELAMOS O, Manubens E, Jain M, Chavez-Bourgeois M, et al
    Improvement of diagnostic confidence and management of equivocal skin lesions by integration of reflectance confocal microscopy in daily practice: Prospective study in 2 referral skin cancer centers.
    J Am Acad Dermatol. 2020;83:1057-1063.
    PubMed     Abstract available


    September 2020
  123. BEHBAHANI S, Malerba S, Warren CJ, Pomeranz MK, et al
    Melanoma In-Situ and Invasive Melanoma of the Vulva: an Analysis of the National Cancer Database.
    J Am Acad Dermatol. 2020 Sep 17. pii: S0190-9622(20)32624.
    PubMed    


  124. LYTVYN Y, Mufti A, Sachdeva M, Maliyar K, et al
    Stevens Johnson Syndrome and Toxic Epidermal Necrolysis Reactions to BRAF and MEK Inhibitors in Patients with Melanoma: A Systematic Review.
    J Am Acad Dermatol. 2020 Sep 11. pii: S0190-9622(20)32613.
    PubMed    


  125. RYU GW, Choi YD, Ryu YJ, Lee JB, et al
    Risk Factors Affecting the First Metastasis of Acral Melanoma: Low-pigmentation Independently Predicts a First Lung Metastasis.
    J Am Acad Dermatol. 2020 Sep 3. pii: S0190-9622(20)32535.
    PubMed    


    August 2020
  126. MCDONALD KA, Krema H, Chan AW
    Cutaneous Signs and Risk Factors for Ocular Melanoma.
    J Am Acad Dermatol. 2020 Aug 29. pii: S0190-9622(20)32496.
    PubMed    


  127. SHAH P, Gulati N, Stein J, Polsky D, et al
    Utility of confocal microscopy in the management of lentigo maligna and lentigo maligna melanoma.
    J Am Acad Dermatol. 2020 Aug 29. pii: S0190-9622(20)32498.
    PubMed    


  128. MARSON JW, Litchman GH, Rigel DS
    The Magnitude of Increased US Melanoma Incidence Attributable to Ground-Level Ultraviolet Radiation Intensity Trends.
    J Am Acad Dermatol. 2020 Aug 29. pii: S0190-9622(20)32497.
    PubMed    


  129. QIAN Y, Johannet P, Sawyers A, Yu J, et al
    The ongoing racial disparities in melanoma: an analysis of the Surveillance, Epidemiology, and End Results database (SEER) database (1975-2016).
    J Am Acad Dermatol. 2020 Aug 27. pii: S0190-9622(20)32494.
    PubMed     Abstract available


  130. ZAFAR FS, Abid R, Ginader T, Powers JG, et al
    Rural Health Disparities in Melanoma Staging and Prognostic Outcomes in Iowa.
    J Am Acad Dermatol. 2020 Aug 26. pii: S0190-9622(20)32489.
    PubMed    


  131. ZHENG YJ, Ho C, Lazar A, Ortiz-Urda S, et al
    Poor melanoma outcomes and survival in Asian Americans and Pacific Islanders.
    J Am Acad Dermatol. 2020 Aug 26. pii: S0190-9622(20)32483.
    PubMed    


  132. CHO KK, Cust AE, Foo MY, Eslick GD, et al
    Melanomas and stress patterns on the foot: a systematic review and meta-analysis.
    J Am Acad Dermatol. 2020 Aug 22. pii: S0190-9622(20)32475.
    PubMed    


  133. GOYAL A, O'Leary D, Goyal K, Patel K, et al
    Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer: a systematic review and meta-analysis.
    J Am Acad Dermatol. 2020 Aug 18. pii: S0190-9622(20)32444.
    PubMed     Abstract available


  134. MASKALANE J, Salijuma E, Lallas K, Papageorgiou C, et al
    Distribution of the dermatoscopic features of melanoma of trunk and extremities according to the anatomic sub-location.
    J Am Acad Dermatol. 2020 Aug 18. pii: S0190-9622(20)32451.
    PubMed    


  135. HAYNES D, Strunck JL, Said J, Tam I, et al
    Association Between Halo Nevi and Melanoma in Adults: A Multi-Center Retrospective Case Series.
    J Am Acad Dermatol. 2020 Aug 18. pii: S0190-9622(20)32449.
    PubMed    


  136. CORTEZ JL, Vasquez J, Wei ML
    The Impact of Demographics, Socioeconomics, and Healthcare Access on Melanoma Outcomes.
    J Am Acad Dermatol. 2020 Aug 9. pii: S0190-9622(20)32405.
    PubMed     Abstract available


  137. CUEVAS RG, Villani A, Apalla Z, Kyrgidis A, et al
    Dermatoscopic predictors of melanoma arising in small- and medium-sized congenital nevi.
    J Am Acad Dermatol. 2020 Aug 4. pii: S0190-9622(20)32348.
    PubMed    


  138. BURNETT ME, Brodland DG, Zitelli JA
    Long-term outcomes of Mohs micrographic surgery for invasive melanoma of the trunk and proximal extremities.
    J Am Acad Dermatol. 2020 Aug 4. pii: S0190-9622(20)32316.
    PubMed     Abstract available


  139. LIPNER SR, Iorizzo M, Jellinek N, Piraccini BM, et al
    Considerations for management of longitudinal melanonychia during the coronavirus disease 2019 (COVID-19) pandemic: An international perspective.
    J Am Acad Dermatol. 2020;83:e159-e161.
    PubMed    


    July 2020
  140. SANO T, Minagawa A, Suzuki R, Koga H, et al
    Dermoscopy with near-ultraviolet light highlights the demarcation of melanin distribution in cutaneous melanoma.
    J Am Acad Dermatol. 2020 Jul 23. pii: S0190-9622(20)32281.
    PubMed    


  141. GUHAN S, Boland G, Tanabe K, Lin W, et al
    Surgical Delay and Mortality for Primary Cutaneous Melanoma.
    J Am Acad Dermatol. 2020 Jul 22. pii: S0190-9622(20)32279.
    PubMed    


  142. KADIOGLU O, Saeed MEM, Greten HJ, Mayr K, et al
    Identification of potential inhibitors targeting BRAF-V600E mutant melanoma cells.
    J Am Acad Dermatol. 2020 Jul 21. pii: S0190-9622(20)32270.
    PubMed    


  143. YANG JJ, Maloney NJ, Cheng K, Bach DQ, et al
    Financial Burden in US Melanoma Patients from 1997-2015: Racial Disparities, Trends, and Predictors of High Expenditures.
    J Am Acad Dermatol. 2020 Jul 17. pii: S0190-9622(20)32220.
    PubMed    


  144. ZHONG CS, Coughlin CC, Hawryluk EB, Hook K, et al
    Characteristics of non-melanoma skin cancer in children without identifiable risk factors.
    J Am Acad Dermatol. 2020 Jul 17. pii: S0190-9622(20)32215.
    PubMed    


  145. BABINO G, Lallas A, Agozzino M, Alfano R, et al
    Melanoma diagnosed on digital dermoscopy monitoring: a side-by-side image comparison is needed to improve early detection.
    J Am Acad Dermatol. 2020 Jul 8. pii: S0190-9622(20)32177.
    PubMed     Abstract available


  146. HAWRYLUK EB, Moustafa D, Bartenstein D, Brahmbhatt M, et al
    A Retrospective Multicenter Study of Fatal Pediatric Melanoma.
    J Am Acad Dermatol. 2020 Jul 1. pii: S0190-9622(20)32110.
    PubMed     Abstract available


  147. SOLEYMANI T, Swetter SM, Hollmig ST, Aasi SZ, et al
    Adequacy of conservative 2- to 3-mm surgical margins for complete excision of biopsy-proven severely dysplastic nevi: Retrospective case series at a tertiary academic institution.
    J Am Acad Dermatol. 2020;83:254-255.
    PubMed    


    June 2020
  148. SABOUR S
    Comment on "The Use of Non-Invasive Imaging Techniques in the Diagnosis of Melanoma: A Prospective Diagnostic Accuracy Study."
    J Am Acad Dermatol. 2020 Jun 24. pii: S0190-9622(20)31176.
    PubMed    


  149. SHAH PV, Choi JN, Fiessinger L, Nardone B, et al
    Utilization of immunotherapy among stage 4 melanoma patients: an analysis of the National Cancer Database from 2012-2016.
    J Am Acad Dermatol. 2020 Jun 14. pii: S0190-9622(20)31092.
    PubMed    


  150. GREENHAW BN, Covington KR, Kurley Phd SJ, Yeniay Y, et al
    Reply to Problematic methodology in a systematic review and meta-analysis of DecisionDx- Melanoma.
    J Am Acad Dermatol. 2020 Jun 8. pii: S0190-9622(20)31069.
    PubMed    


  151. MARCHETTI MA, Dusza SW, Bartlett EK
    Problematic methodology in a systematic review and meta-analysis of DecisionDx-Melanoma(R).
    J Am Acad Dermatol. 2020 Jun 8. pii: S0190-9622(20)31068.
    PubMed    


  152. LIU R, Ferris LK
    Reply to Comment on "Re-Evaluating the ABCD Criteria Using a Consecutive Series of Melanomas".
    J Am Acad Dermatol. 2020 Jun 2. pii: S0190-9622(20)30971.
    PubMed    


  153. JAFRY MA, Peacock S, Radick AC, Shucard HL, et al
    Pathologists' agreement on treatment suggestions for melanocytic skin lesions.
    J Am Acad Dermatol. 2020;82:1435-1444.
    PubMed     Abstract available


    May 2020
  154. REYNOLDS HH, Stancut E, Pavlidakey PG, Huang CC, et al
    Efficacy of Staged Excision with Permanent Section Margin Control for Melanoma In Situ.
    J Am Acad Dermatol. 2020 May 28. pii: S0190-9622(20)30978.
    PubMed    


  155. GOLDSMITH SM
    Comment on "Re-Evaluating the ABCD Criteria Using a Consecutive Series of Melanomas".
    J Am Acad Dermatol. 2020 May 23. pii: S0190-9622(20)30970.
    PubMed    


  156. RACHIDI S, Deng Z, Sullivan DY, Lipson EJ, et al
    Shorter survival and later stage at diagnosis among unmarried patients with cutaneous melanoma: a US national and tertiary care center study.
    J Am Acad Dermatol. 2020 May 21. pii: S0190-9622(20)30958.
    PubMed     Abstract available


  157. BRAGHIROLI NF, Grant-Kels JM, Oliviero M, Rabinovitz H, et al
    The role of reflectance confocal microscopy in differentiating melanoma in situ from dysplastic nevi with severe atypia: a cross-sectional study.
    J Am Acad Dermatol. 2020 May 19. pii: S0190-9622(20)30939.
    PubMed     Abstract available


  158. MARCHETTI MA, Liopyris K, Navarrete-Dechent C
    Net benefit and decision curve analysis of competing diagnostic strategies for cutaneous melanoma.
    J Am Acad Dermatol. 2020 May 6. pii: S0190-9622(20)30830.
    PubMed    


  159. PRASSINOS A, Glusac E, Leffell DJ
    Melanoma in situ: Don't make the cure worse than the disease.
    J Am Acad Dermatol. 2020 May 6. pii: S0190-9622(20)30825.
    PubMed    


  160. SANCHEZ DP, Maymone MBC, McLean EO, Kennedy KF, et al
    Racial and Ethnic disparities in Melanoma Awareness: A Cross-Sectional Survey.
    J Am Acad Dermatol. 2020 May 4. pii: S0190-9622(20)30758.
    PubMed     Abstract available


  161. BARRIERA-SILVESTRINI P, Xiong DD, Lewis S, Knackstedt T, et al
    Melanoma Incidence and Survival in Patients with Myelodysplastic Syndrome: A Matched Cohort Population-Based Study.
    J Am Acad Dermatol. 2020 May 3. pii: S0190-9622(20)30770.
    PubMed    


  162. LI X, Kraft P, De Vivo I, Giovannucci E, et al
    Height, nevus count, and risk of cutaneous malignant melanoma: results from two large cohorts of US women.
    J Am Acad Dermatol. 2020 May 3. pii: S0190-9622(20)30783.
    PubMed     Abstract available


  163. PEREZ-ANKER J, Puig S, Malvehy J
    A fast and effective option for tissue flattening: Optimizing time and efficacy in ex vivo confocal microscopy.
    J Am Acad Dermatol. 2020;82:e157-e158.
    PubMed    


    April 2020
  164. FRIED L, Tan A, Bajaj S, Liebman TN, et al
    Technological advances for the detection of melanoma: Part II. Advances in molecular techniques.
    J Am Acad Dermatol. 2020 Apr 29. pii: S0190-9622(20)30739.
    PubMed     Abstract available


  165. MARCHETTI MA, Yu A, Nanda J, Tschandl P, et al
    Number Needed to Biopsy (NNB) Ratio and Diagnostic Accuracy for Melanoma Detection.
    J Am Acad Dermatol. 2020 Apr 28. pii: S0190-9622(20)30725.
    PubMed     Abstract available


  166. ZALAUDEK I, Conforti C, Guarneri F, Vezzoni R, et al
    Clinical and dermoscopic characteristics of congenital and non-congenital nevus-associated melanomas.
    J Am Acad Dermatol. 2020 Apr 28. pii: S0190-9622(20)30737.
    PubMed     Abstract available


  167. WILSON JG, German R, Hamann CR, Vidal NY, et al
    Comparison of staged excision and Mohs Micrographic Surgery with and without MART-1 immunostains for surgical treatment of melanoma of the head, neck, and special sites: a retrospective cohort study.
    J Am Acad Dermatol. 2020 Apr 26. pii: S0190-9622(20)30697.
    PubMed    


  168. FRIED L, Tan A, Bajaj S, Liebman TN, et al
    Technological advances for the detection of melanoma: Part I. Advances in diagnostic techniques.
    J Am Acad Dermatol. 2020 Apr 26. pii: S0190-9622(20)30738.
    PubMed     Abstract available


  169. SHIN TM, Nugent S, Aizman L, Weiner DM, et al
    Mohs micrographic surgery with MART-1 immunostaining has durable low local recurrence rates for in situ and invasive melanomas.
    J Am Acad Dermatol. 2020 Apr 24. pii: S0190-9622(20)30702.
    PubMed    


  170. LIU R, Pugliano-Mauro M, Patton T, Wang L, et al
    Re-Evaluating the ABCD Criteria Using a Consecutive Series of Melanomas.
    J Am Acad Dermatol. 2020 Apr 22. pii: S0190-9622(20)30691.
    PubMed    


  171. LOBO MM, Calsavara VF, Ricci BV, Lopes Pinto CA, et al
    Response rates of cutaneous melanoma metastases to diphencyprone: a meta-analysis.
    J Am Acad Dermatol. 2020 Apr 11. pii: S0190-9622(20)30563.
    PubMed    


  172. MEGARIS A, Lallas A, Bagolini LP, Balais G, et al
    Dermatoscopic features of melanomas with a diameter up to 5mm (micromelanomas): a retrospective study.
    J Am Acad Dermatol. 2020 Apr 11. pii: S0190-9622(20)30545.
    PubMed    


  173. MACLELLAN AN, Price EL, Publicover-Brouwer P, Matheson K, et al
    The Use of Non-Invasive Imaging Techniques in the Diagnosis of Melanoma: A Prospective Diagnostic Accuracy Study.
    J Am Acad Dermatol. 2020 Apr 11. pii: S0190-9622(20)30559.
    PubMed     Abstract available


  174. SARGEN MR, Calista D, Elder DE, Massi D, et al
    Histologic features of melanoma associated with germline mutations of CDKN2A, CDK4, and POT1 in melanoma-prone families from the United States, Italy, and Spain.
    J Am Acad Dermatol. 2020 Apr 10. pii: S0190-9622(20)30523.
    PubMed     Abstract available


  175. LIM Y, Yoon D, Lee DY
    Novel Mutations Identified by Whole Exome Sequencing in Acral Melanoma.
    J Am Acad Dermatol. 2020 Apr 9. pii: S0190-9622(20)30536.
    PubMed    


  176. TRIPATHI R, Archibald LK, Mazmudar RS, Conic RR, et al
    Racial Differences in Time to Treatment for Melanoma.
    J Am Acad Dermatol. 2020 Apr 8. pii: S0190-9622(20)30517.
    PubMed     Abstract available


  177. BEATSON M, Eleryan MG, Reserva J, Kaufman B, et al
    Importance of Pathology Review to Complement Clinical Management of Melanoma.
    J Am Acad Dermatol. 2020 Apr 5. pii: S0190-9622(20)30516.
    PubMed    


  178. PEEK G, Olsen CM, Baade P, Youlden DR, et al
    Survival in Patients with Multiple Primary Melanomas: Systematic Review and Meta-analysis.
    J Am Acad Dermatol. 2020 Apr 1. pii: S0190-9622(20)30499.
    PubMed     Abstract available


  179. FRIEDMAN BJ, Lee JB
    Spitz nevi in older adults: Correlation of histopathology with results of a gene expression profiling assay.
    J Am Acad Dermatol. 2020;82:1021-1023.
    PubMed    


  180. BATCHELDER E, Straight C, Butt M, Kirby JS, et al
    Information framing effects on patients' decisions about dysplastic nevus management.
    J Am Acad Dermatol. 2020;82:1011-1013.
    PubMed    


    March 2020
  181. GREENHAW BN, Covington KR, Kurley SJ, Yeniay Y, et al
    Molecular risk prediction in cutaneous melanoma: a meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients.
    J Am Acad Dermatol. 2020 Mar 27. pii: S0190-9622(20)30475.
    PubMed     Abstract available


  182. BAGOLINI LP, Apalla Z, Cuevas RG, Lallas K, et al
    Dermatoscopic predictors to discriminate between in situ and early invasive lentigo maligna melanoma: A retrospective observational study.
    J Am Acad Dermatol. 2020 Mar 18. pii: S0190-9622(20)30444.
    PubMed    


  183. MONTAUDIE H, Le Duff F, Butori C, Hofman V, et al
    Ingenol mebutate to treat lentigo maligna of the head (face and scalp): A prospective, multicenter, single-arm phase 2 trial indicates no benefit.
    J Am Acad Dermatol. 2020;82:731-733.
    PubMed    


    February 2020
  184. GREENWALD E, Tan A, Stein JA, Liebman TN, et al
    Real world outcomes of melanoma surveillance using the MoleMap NZ telemedicine platform.
    J Am Acad Dermatol. 2020 Feb 27. pii: S0190-9622(20)30301.
    PubMed     Abstract available


  185. PARK CK, Dahlke EJ, Fung K, Kitchen J, et al
    Melanoma incidence, stage, and survival after solid organ transplant: A population-based cohort study in Ontario, Canada.
    J Am Acad Dermatol. 2020 Feb 25. pii: S0190-9622(19)32821.
    PubMed     Abstract available


  186. YANG K, Mahalingam M
    Differing biologic behaviors of Desmoplastic melanoma subtypes - insights based on histopathological, immunohistochemical and genetic analyses.
    J Am Acad Dermatol. 2020 Feb 14. pii: S0190-9622(20)30222.
    PubMed     Abstract available


  187. LEE MH, Kim YJ, Yun KA, Won CH, et al
    Prognostic Significance of CD200 Protein Expression and its Correlation with COX-2 in Cutaneous Melanoma.
    J Am Acad Dermatol. 2020 Feb 7. pii: S0190-9622(20)30210.
    PubMed    


  188. VON SCHUCKMANN LA, Khosrotehrani K, Celia B Hughes M, van der Pols JC, et al
    Prognostic implications of biopsy with tumour transection for high-risk primary melanoma patients.
    J Am Acad Dermatol. 2020 Feb 4. pii: S0190-9622(20)30153.
    PubMed    


  189. HEYMANN WR
    Juvenile lichen sclerosus: A loss of innocence.
    J Am Acad Dermatol. 2020;82:301-302.
    PubMed    


  190. CHAN L, Hwang SJE, Byth K, Kyaw M, et al
    Survival and prognosis of individuals receiving programmed cell death 1 inhibitor with and without immunologic cutaneous adverse events.
    J Am Acad Dermatol. 2020;82:311-316.
    PubMed     Abstract available


  191. KRISTENSEN KB, Pedersen SA, Schmidt SAJ, Pottegard A, et al
    Use of antiepileptic drugs and risk of skin cancer: A nationwide case-control study.
    J Am Acad Dermatol. 2020;82:326-335.
    PubMed     Abstract available


  192. CROLEY JA, Joseph AK, Wagner RF Jr
    Discrepancies in the Mohs Micrographic Surgery appropriate use criteria.
    J Am Acad Dermatol. 2020;82:e55.
    PubMed    


    January 2020
  193. HAITZ K, Khosravi H, Lin JY, Menge T, et al
    Review of Talimogene Laherparepvec (T-VEC): A First in Class Oncolytic Viral Treatment of Advanced Melanoma.
    J Am Acad Dermatol. 2020 Jan 28. pii: S0190-9622(20)30123.
    PubMed     Abstract available


  194. KUNISHIGE JH, Brodland DG, Zitelli JA
    RESPONSE TO LETTER TO THE EDITOR TITLED 5-MM LATERAL MARGINS ARE APPROPRIATE IN THE TREATMENT OF MELANOMA IN SITU.
    J Am Acad Dermatol. 2020 Jan 11. pii: S0190-9622(20)30051.
    PubMed    


  195. VALENCIA P, Chaparro L, Rico P, Gomez L, et al
    Five-millimeter lateral margins are appropriate in the treatment of melanoma in situ.
    J Am Acad Dermatol. 2020 Jan 11. pii: S0190-9622(20)30050.
    PubMed    


  196. PETTY AJ, Ackerson B, Garza R, Peterson M, et al
    Meta-Analysis of Number Needed to Treat for Diagnosis of Melanoma by Clinical Setting.
    J Am Acad Dermatol. 2020 Jan 10. pii: S0190-9622(20)30042.
    PubMed     Abstract available


  197. FLEMING NH, Shaub AR, Bailey E, Swetter SM, et al
    Outcomes of surgical re-excision versus observation of severely dysplastic nevi: A single-institution, retrospective cohort study.
    J Am Acad Dermatol. 2020;82:238-240.
    PubMed    


  198. BEAULIEU D, Tsao H, Michaud DS, Okhovat JP, et al
    Number needed to screen for presumptive screening diagnoses among first-time SPOTme screening participants (1992-2010).
    J Am Acad Dermatol. 2020;82:233-234.
    PubMed    


  199. PRIVALLE A, Havighurst T, Kim K, Bennett DD, et al
    Number of skin biopsies needed per malignancy: Comparing the use of skin biopsies among dermatologists and nondermatologist clinicians.
    J Am Acad Dermatol. 2020;82:110-116.
    PubMed     Abstract available


    December 2019
  200. NAVARRETE-DECHENT C, Cordova M, Aleissa S, Liopyris K, et al
    Lentigo maligna melanoma mapping using reflectance confocal microscopy correlates with staged excision: A prospective study.
    J Am Acad Dermatol. 2019 Dec 5. pii: S0190-9622(19)33150.
    PubMed     Abstract available


  201. LEE K
    JAAD Game Changers: The association of indoor tanning and melanoma in adults: Systematic review and meta-analysis.
    J Am Acad Dermatol. 2019 Dec 3. pii: S0190-9622(19)33142.
    PubMed    


  202. LAKE E
    JAAD Game Changers: Racial disparities in melanoma survival.
    J Am Acad Dermatol. 2019 Dec 3. pii: S0190-9622(19)33148.
    PubMed    


  203. LEE K
    JAAD Game Changers: Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp.
    J Am Acad Dermatol. 2019 Dec 3. pii: S0190-9622(19)33144.
    PubMed    


    November 2019
  204. ADELMAN M, Lyons AB, Seale L, Friedman BJ, et al
    Use of p16 immunohistochemical stain to help differentiate inflamed melanocytic nevi from metastatic melanoma in the setting of immunotherapy.
    J Am Acad Dermatol. 2019 Nov 22. pii: S0190-9622(19)33125.
    PubMed    


  205. KUNISHIGE JH, Brodland D, Zitelli JA
    RESPONSE TO "HISTOLOGIC CRITERIA FOR ASSESSING SURGICAL MARGINS IN MELANOMA IN SITU".
    J Am Acad Dermatol. 2019 Nov 18. pii: S0190-9622(19)33121.
    PubMed    


  206. GROSSMAN D, Florell SR, Duffy KL, Bowen GM, et al
    Histologic criteria for assessing surgical margins in melanoma in situ.
    J Am Acad Dermatol. 2019 Nov 18. pii: S0190-9622(19)33120.
    PubMed    


  207. LOBL MB, Santos C, Clarey D, Higgins S, et al
    Treatments and associated outcomes of acral lentiginous melanoma: A review.
    J Am Acad Dermatol. 2019 Nov 15. pii: S0190-9622(19)33111.
    PubMed    


  208. NARDIN C, Jeand'heur A, Bouiller K, Valnet-Rabier MB, et al
    Vitiligo under anti-PD1 therapy is associated with increased survival in melanoma patients.
    J Am Acad Dermatol. 2019 Nov 14. pii: S0190-9622(19)33107.
    PubMed    


  209. LALLAS A, Apalla Z
    Reply to REPLY to MS#JAAD-D-19-02180 "Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring".
    J Am Acad Dermatol. 2019 Nov 7. pii: S0190-9622(19)33002.
    PubMed    


  210. ALESSIA V, Fabbrocini G, Greco V, Costa C, et al
    Reply to Lallas A. et al. "Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring".
    J Am Acad Dermatol. 2019 Nov 7. pii: S0190-9622(19)33001.
    PubMed    


  211. MAOR D, Vajdic CM, Cumming S, Fahey V, et al
    Melanoma in a cohort of organ transplant recipients: Experience from a dedicated transplant dermatology clinic in Victoria, Australia.
    J Am Acad Dermatol. 2019 Nov 7. pii: S0190-9622(19)33009.
    PubMed     Abstract available


  212. DRUGGE ED, Sarac RM, Elston DM, Drugge RJ, et al
    Correlation of total body photography frequency and invasive melanoma depth.
    J Am Acad Dermatol. 2019 Nov 7. pii: S0190-9622(19)33003.
    PubMed    


  213. IPENBURG NA, Lo SN, Vilain RE, Holtkamp LHJ, et al
    The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: a retrospective cohort study.
    J Am Acad Dermatol. 2019 Nov 1. pii: S0190-9622(19)32989.
    PubMed     Abstract available


    October 2019
  214. HERR MM, Curtis RE, Tucker MA, Tecca HR, et al
    Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation.
    J Am Acad Dermatol. 2019 Oct 22. pii: S0190-9622(19)32952.
    PubMed     Abstract available


  215. BEROUKHIM K, Pourang A, Eisen DB
    Risk of second primary cutaneous and non-cutaneous melanoma following cutaneous melanoma diagnosis: A population-based study.
    J Am Acad Dermatol. 2019 Oct 15. pii: S0190-9622(19)32908.
    PubMed     Abstract available


  216. SEIGER K, Schmults CD, Silk AW, Ruiz ES, et al
    Cost and Utilization of Immunotherapy and Targeted Therapy for Melanoma: Cross-Sectional Analysis in the Medicare Population, 2013 and 2015.
    J Am Acad Dermatol. 2019 Oct 15. pii: S0190-9622(19)32907.
    PubMed    


  217. KUNISHIGE JH, Doan L, Brodland DG, Zitelli JA, et al
    9-mm Surgical margin required for both LM and MIS as diagnosed in real-world community practice.
    J Am Acad Dermatol. 2019;81:e117-e118.
    PubMed    


    September 2019
  218. WALDMAN RA, Grant-Kels JM, Curiel CN, Curtis J, et al
    Consensus Recommendations for the Use of Non-Invasive Melanoma Detection Techniques Based on Results of an International DELPHI Process.
    J Am Acad Dermatol. 2019 Sep 26. pii: S0190-9622(19)32794.
    PubMed    


  219. OH Y, Choi S, Cho MY, Nam KA, et al
    Male sex and Breslow thickness are important risk factors for recurrence of localized melanoma in Korean populations.
    J Am Acad Dermatol. 2019 Sep 25. pii: S0190-9622(19)32773.
    PubMed     Abstract available


  220. KONG L, Tan K, Tan H, Li J, et al
    Utilization of Magnetic Resonance Imaging as a Non-Invasive Imaging Technique To Identify Acral Lentiginous Melanoma.
    J Am Acad Dermatol. 2019 Sep 24. pii: S0190-9622(19)32769.
    PubMed    


  221. ZHOU Y, Chen W, Liu ZR, Liu J, et al
    Modified shave surgery combined with nail window technique for the treatment of longitudinal melanonychia: Evaluation of the method on a series of 67 cases.
    J Am Acad Dermatol. 2019;81:717-722.
    PubMed     Abstract available


    August 2019
  222. SAVOIA F, Ravaioli GM, Tabanelli M, Dika E, et al
    Scraping test for the diagnosis of acral subcorneal hemorrhage.
    J Am Acad Dermatol. 2019;81:e29-e30.
    PubMed    


  223. WYSONG A, Higgins S, Blalock TW, Ricci D, et al
    Defining skin cancer local recurrence.
    J Am Acad Dermatol. 2019;81:581-599.
    PubMed     Abstract available


  224. NELSON KC, Gershenwald JE, Savory SA, Wilson JM, et al
    Telementoring and smartphone-based answering systems to optimize dermatology resident dermoscopy education.
    J Am Acad Dermatol. 2019;81:e27-e28.
    PubMed    


    June 2019
  225. DELLATORRE G, Gadens GA
    Wide area digital dermoscopy.
    J Am Acad Dermatol. 2019;80:e153.
    PubMed    


  226. YELAMOS O, Navarrete-Dechent C, Marchetti MA, Rogers T, et al
    Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society.
    J Am Acad Dermatol. 2019;80:1585-1593.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: